Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes

Frontiers Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy

Novel and Emerging Treatment Strategies for Acute Myeloid Leukemia in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 7.5 (2020)

Current status and future perspectives in targeted therapy of NPM1-mutated AML

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

Options for imaging cellular therapeutics in vivo: a multi-stakeholder perspective - Cytotherapy

Pediatric acute lymphoblastic leukemia

Leukemia Drug Trial Reveals How Cancer Cells Resist Therapy

Cancers, Free Full-Text

Therapeutic implications of menin inhibition in acute leukemias